Verastem, Inc. (VSTM) Debt Components
- 2026-06-30: Secured Debt, CurrentUSD (m); Notes Payable, CurrentUSD $214.00K; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2026-03-31: Secured Debt, CurrentUSD (m); Notes Payable, CurrentUSD $529.00K; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-12-31: Secured Debt, CurrentUSD (m); Notes Payable, CurrentUSD (m); Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-09-30: Secured Debt, CurrentUSD (m); Notes Payable, CurrentUSD $188.00K; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
Verastem, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Secured Debt, Current USD | Notes Payable, Current USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-term Debt, Gross USD | Debt, Long-term and Short-term, Combined Amount USD | Debt Instrument, Unamortized Discount (Premium), Net USD | Notes Payable, Fair Value Disclosure USD | Convertible Notes Payable, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Debt Instrument, Convertible, Conversion Ratio pure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $214.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $529.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $76.33M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $188.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $467.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $740.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $40.72M | (m) | (m) | (m) | $40.00M | (m) | $448.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $15.00M | $20.00M | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $9.87M | $133.00K | $40.52M | $15.00M | $20.00M | $5.00M | $40.00M | $30.65M | $520.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $4.93M | $526.00K | $40.32M | $15.00M | $20.00M | $5.00M | $40.00M | $35.39M | $591.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $911.00K | $40.12M | $15.00M | $20.00M | $5.00M | $40.00M | (m) | $659.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $40.09M | (m) | (m) | (m) | $40.00M | (m) | $575.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $40.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | $15.00M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.00M | (m) | (m) |
| 2023-09-30 | (m) | $146.00K | $39.91M | (m) | (m) | $15.00M | $40.00M | (m) | $628.00K | (m) | (m) | (m) | (m) | $20.00M | $5.00M | (m) |
| 2023-06-30 | (m) | $579.00K | $39.74M | (m) | (m) | $15.00M | $40.00M | (m) | $680.00K | (m) | (m) | (m) | (m) | $20.00M | $5.00M | (m) |
| 2023-03-31 | (m) | $1.00M | $39.57M | (m) | (m) | $15.00M | $40.00M | (m) | $730.00K | (m) | (m) | (m) | (m) | $20.00M | $5.00M | (m) |
| 2022-12-31 | (m) | (m) | $24.53M | (m) | (m) | (m) | $25.00M | (m) | $699.00K | (m) | $275.00K | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | $6.25M | $8.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $8.33M | $2.08M | (m) |
| 2022-09-30 | (m) | (m) | $24.40M | (m) | $6.25M | $8.33M | $25.00M | (m) | $750.00K | (m) | (m) | (m) | (m) | $8.33M | $2.08M | (m) |
| 2022-06-30 | (m) | (m) | $24.28M | (m) | $6.25M | $8.33M | $25.00M | (m) | $800.00K | (m) | (m) | (m) | (m) | $8.33M | $2.08M | (m) |
| 2022-03-31 | (m) | (m) | $24.16M | (m) | $6.25M | $8.33M | $25.00M | (m) | $848.00K | (m) | (m) | (m) | (m) | $8.33M | $2.08M | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $9.30M | (m) | $35.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $4.59M | (m) | $35.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $35.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $35.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $35.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | $34.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $34.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | $25.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $5.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $25.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-10-17 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1163.14% |
| 2018-09-30 | (m) | (m) | $25.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.53M | $21.54M | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $24.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.38M | $23.52M | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $14.91M | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $14.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $14.83M | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | (m) | $3.61B | $11.39B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.33M | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.29M | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.25M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |